Neuroscience
Polyneuropathy
100%
Diabetic Neuropathy
89%
Amyotrophic Lateral Sclerosis
89%
Motor Unit
84%
Nerve Conduction Study
71%
Electromyography
54%
Action Potential
48%
Nerve Excitability
32%
Muscle Fiber Membrane
29%
Transcranial Magnetic Stimulation
29%
Electrodiagnosis
28%
Peripheral Nerve
25%
Refractory Period
21%
Sural Nerve
21%
Motor Neuron Disease
19%
Muscle Excitability
19%
Oxaliplatin
18%
Placebo
18%
Diabetes Mellitus
17%
Magnetoencephalography
17%
Excitability
17%
Nerve Fiber
17%
Diagnosis of Amyotrophic Lateral Sclerosis
17%
Quantitative Sensory Testing
16%
Neuropathic Pain
16%
Motor Evoked Potential
14%
Electromyography
14%
Upper Motor Neuron
14%
Axonal Excitability
13%
Afferent Nerve Fiber
13%
Sensory Nerve
13%
Neurofilament Light Chain
13%
Immunotherapy
13%
Magnetic Resonance Imaging
13%
Lacosamide
13%
Peripheral Nervous System
12%
Axon
12%
Autonomic Neuropathy
11%
Spinal Cord Injury
11%
Risk Factor
10%
Laser Evoked Potential
9%
Intravenous Immunoglobulin
9%
Heart Rate Variability
8%
Histopathology
8%
Skeletal Muscle
8%
Plantar Flexors
8%
Somatosensory Evoked Potential
8%
Tapentadol
8%
Pregabalin
8%
In Vivo
8%
Medicine and Dentistry
Diabetic Neuropathy
97%
Polyneuropathy
92%
Motor Unit Number Estimation
53%
Nerve Conduction Study
51%
Maturity Onset Diabetes of the Young
50%
Amyotrophic Lateral Sclerosis
49%
Motor Unit
39%
Nerve Excitability
29%
Electromyography
29%
Compound Muscle Action Potential
28%
Peripheral Nerve
26%
Spinal Cord Injury
26%
Electrodiagnosis
24%
Diabetes
22%
Insulin Dependent Diabetes Mellitus
22%
Cross Sectional Study
21%
Excitability
20%
Action Potential Amplitude
20%
Sural Nerve
20%
Nerve Fiber
18%
Patient with Type 2 Diabetes
18%
Placebo
17%
Neuropathic Pain
16%
Prevalence
16%
Diagnosis of Amyotrophic Lateral Sclerosis
15%
Reflex Arc
15%
Hemoglobin A1c
14%
Nicotinamide Adenine Dinucleotide
14%
Oxaliplatin
14%
Chronic Inflammatory Demyelinating Polyneuropathy
14%
Biological Marker
13%
Diffusion Tensor Imaging
13%
Reproducibility
13%
Autonomic Neuropathy
13%
Diabetes Mellitus
13%
Early Diagnosis
13%
Histopathology
13%
Neurography
13%
Lacosamide
13%
Tibial Nerve
13%
Muscle Fiber Membrane
13%
Prospective Study
12%
Critical Illness
11%
Motor Unit Potential
11%
Peripheral Nervous System
11%
Adjuvant Chemotherapy
11%
Transcranial Magnetic Stimulation
9%
Refractory Period
9%
Immunoglobulin
9%
Motor Neuron Disease
9%
Keyphrases
Diabetic Neuropathy
79%
Polyneuropathy
49%
Type 2 Diabetes Mellitus (T2DM)
38%
Motor Unit number Index (MUNIX)
38%
Amyotrophic Lateral Sclerosis
37%
MScanFit
35%
Nerve Conduction Studies
31%
Healthy Controls
25%
Intracortical Inhibition
24%
Type 2 Diabetic Patients
17%
Large Mode Area Fiber
17%
Adolescents with Type 1 Diabetes
17%
Risk Factors
17%
Muscle Velocity Recovery Cycles
16%
Denmark
15%
Neurofilament Light (NF-L)
14%
Oxaliplatin
13%
Peripheral Nerve
13%
Electrodiagnosis
13%
COVID-19
13%
Painful Diabetic Neuropathy
13%
Diffusion Tensor Imaging
12%
Critical Illness Myopathy
12%
Docetaxel
11%
Adjuvant Chemotherapy
10%
Type I Diabetes
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Potential Biomarkers
10%
Neuropathic Pain
10%
Chronic Inflammatory Demyelinating Polyneuropathy
10%
Guillain-Barré Syndrome
9%
Compound muscle Action Potential
9%
Threshold Tracking Transcranial Magnetic Stimulation
9%
Tibial Nerve
9%
Small Fiber Neuropathy
9%
Nerve Conduction
9%
Early Diagnosis
9%
Autonomic Neuropathy
9%
Nerve
9%
Magnetic Resonance Neurography
8%
Short-latency Afferent Inhibition
8%
Postural Instability
8%
Bedside Test
8%
ICU-acquired Weakness
8%
Serum Neurofilament Light Chain
8%
Peripheral Nerve Excitability
8%
Hemoglobin A1c (HbA1c)
8%
Examination Strategy
8%
Sciatic Nerve
8%
Screen-detected
8%
